Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.8 HKD | +4.00% | -1.65% | -11.68% |
04-29 | CanSino Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-22 | Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.68% | 1.19B | |
-3.35% | 88.91B | |
+4.08% | 41.25B | |
-15.09% | 31.99B | |
+51.77% | 24.73B | |
-15.13% | 15.54B | |
-8.63% | 12.05B | |
-40.39% | 12.07B | |
+6.22% | 8.84B | |
-5.15% | 8.3B |
- Stock Market
- Equities
- 6185 Stock
- News CanSino Biologics Inc.
- Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine